GAMP® 5 as applied to FDA software validation – strategies to avoid warning letters
This GAMP® 5 training/Webinar will discuss on the GAMP® software validation model and the defined process of GAMP® 5 as it applied to FDA software validation.
Why Should You Attend:
Many companies struggle with understanding what FDA, MHRA, EU and other Ministries of Health want to see regarding software validation.This presentation will review the FDA validation process, the GAMP® software validation model, and the process defined in GAMP® 5 as it applies to FDA software validation. The attendee should leave the presentation confident in their ability to understand and apply the GAMP® 5 process.
FDA inspectors are now being trained to evaluate software validation practices.
Increasing use of automated manufacturing and quality systems means increased exposure
Most recalls can be traced back to computerized equipment, exposing the validation process to scrutiny
Corporate uncertainty leads to inaction and ‘wheel spinning’
A third of recent warning letters included citations with respect to improper or ineffective validation
Areas Covered in the Webinar:
Outline of FDA regulations as applied to software.
Review of FDA software validation requirements.
Why validation makes good business sense.
Strategies on how to avoid the most common problems.
The GAMP® approach.
Advice on successful validation project staffing.
GAMP® 5 Principles.
GAMP® 5 as applied to FDDA software validation.
Using GAMP® 5 to cut validation costs.
Who Will Benefit:
This seminar will give valuable help to FDA regulated Pharmaceutical, Medical Device, Biotech, Diagnostics and Biological manufacturers. The staff members who will benefit include:
System owners – responsible for keeping individual systems in validation
Policy makers fof software validation and software quality
Software development life cycle (SDLC) personnel
QA / QC managers, executives and personnel
IT / IS managers and personnel
Validation specialists
Software quality reviewers
Consultants